Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2013 Dec 4;143(1):189–201. doi: 10.1007/s10549-013-2796-3

Table 4.

Selected copy number imbalances predicting breast cancer site specific non-bone metastasis, from the CoxBoost analysis in the discovery

CNI marker Lung metastasis (n = 59)
Liver metastasis (n = 35)
Brain metastasis (n = 47) #
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
2p11.2 gain 4.56 (1.83–11.42) 0.0012 1.75 (0.24–11.81) 0.5811 5.43 (2.14–13.75) 0.0004
3q21.3–22.2 gain 4.90 (2.32–10.32) 2.96 × 10−5 0 (0-Infinity) 4.87 (2.06–11.51) 0.0003
3q27.1 gain 3.50 (1.82–6.74) 0.0002 1.00 (0.24–4.18) 0.9965 4.54 (2.31–8.92) 1.16 × 10−5
7q21.11 loss 3.13 (0.76–12.83) 0.113 2.97 (0.41–21.71) 0.2839 4.31 (1.04–17.81) 0.0435
10q23.1 gain 4.03 (1.73–9.37) 0.0012 2.22 (0.53–9.28) 0.2734 2.34 (0.73–7.56) 0.154
11q13.5 gain 1.45 (0.58–3.63) 0.4281 2.40 (0.93–6.2) 0.07 3.64 (1.76–7.56) 0.0005
14q13.2–3 gain 3.94 (1.93–8.01) 0.0002 1.53 (0.37–6.38) 0.5608 3.05 (1.20–7.72) 0.0187

Abbreviations: CNI, copy number imbalance; HR, hazard ratio; CI, confidence interval.

#

Because there were only 9 patients with first metastasis to brain, we expanded this group to include those with any brain metastasis to improve the power.